FDA Approved: HEPARIN SODIUM AND DEXTROSE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Heparin Sodium and Dextrose (Hospira, Inc.). The update concerns labeling/indications for this anticoagulant product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Deep Vein Thrombosis
• Myocardial Infarction
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM)

Snippet

SUPPL AP for HEPARIN SODIUM AND DEXTROSE (HEPARIN SODIUM)